Alan A. Ades is Director & 10% Owner at Organogenesis Holdings Inc. (ORGO). They have made 1 open-market trade across 1 company since 2019, most recently 2024-12-31.
CIK 0001757286
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $473K since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ORGO | 51,085,403 | $51.1M |
Shares reported on the most recent Form 4, priced at the 2025-01-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ORGO | BUY | 2019-09-03 | 2019-09-05 | $4.50 | $473K | +20.9% | +45.5% | -0.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.